Sucraid® (sacrosidase) Oral Solution
Congenital Sucrase-Isomaltase Deficiency (CSID)
ApprovedActive
Key Facts
Indication
Congenital Sucrase-Isomaltase Deficiency (CSID)
Phase
Approved
Status
Active
Company
About QOL Medical
QOL Medical, LLC is a privately held, commercial-stage biopharmaceutical company headquartered in Cary, North Carolina, USA. The company operates as a specialty commercializer, acquiring and marketing FDA-approved therapies for rare and orphan diseases, with a current portfolio of two products. Its business model centers on providing expanded clinical awareness and patient access for complex, low-prevalence conditions. The company is also actively seeking to acquire or partner on additional biopharmaceutical products to grow its rare disease portfolio.
View full company profileTherapeutic Areas
Other Congenital Sucrase-Isomaltase Deficiency (CSID) Drugs
| Drug | Company | Phase |
|---|---|---|
| PER312 | Perseo Pharma | Preclinical |